In some experimental models, transfer of either CD4 or CD8 cells activated TDLN cells induced in vivo tumor regression, while in other models CD4 alone or CD8 alone was therapeutically ineffective [15, 21, 23]. This evidence concerns the gene CD8A and neoplasm.